Elixi

29 August 2020

Roche announces FDA approval of FoundationOne Liquid CDx, a comprehensive pan-tumour liquid biopsy test

0 Comments4 Minutes

14 August 2020

Vaginal ring to reduce the risk of HIV infection for women in non-EU countries with high disease burden

0 Comments4 Minutes

14 August 2020

Rozlytrek, Roche’s first tumour-agnostic therapy, approved in Europe for people with NTRK fusion-positive solid tumours and for people with ROS1-positive advanced non-small cell lung cancer

0 Comments4 Minutes

24 July 2020

Blenrep (belantamab mafodotin), new option for the treatment of relapsed and refractory multiple myeloma

0 Comments3 Minutes

14 July 2020

Inqovi (decitabine and cedazuridine), new Therapy for Myelodysplastic Syndromes (MDS) That Can Be Taken at Home

0 Comments2 Minutes

7 July 2020

Rukobia (fostemsavir), a new antiretroviral medication for patients who have run out of HIV treatment options

0 Comments3 Minutes

12 June 2020

Uplizna (inebilizumab-cdon)Therapy for Neuromyelitis Optica Spectrum Disorder Offers Patients Additional Treatment Option

0 Comments4 Minutes

6 June 2020

FDA Approves Merck’s RECARBRIO (imipenem, cilastatin, and relebactam) for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP)

0 Comments3 Minutes

29 May 2020

FDA Approves Oriahnn (an estrogen and progestin combination product consisting of elagolix, estradiol and norethindrone acetate)to Treat Heavy Menstrual Bleeding Associated with Fibroids in Women

0 Comments6 Minutes

19 May 2020

Qinlock (ripretinib) is the First Drug for Fourth-Line Treatment of Advanced Gastrointestinal Stromal Tumors

0 Comments4 Minutes